MIR892C

Across TCGA pan-cancer cohorts, MIR892C RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR892C data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR892C RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR892C expression acts as an unfavorable survival marker.

HNSC, STAD, and KIRP are the cancer types where MIR892C RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.163	0.696	.007	72	view →
STAD	OS	Tertile	IV	0.075	0.496	.013	18	view →
KIRP	OS	Tertile	All	0.599	0.903	.017	18	view →
UCEC	OS	Tertile	All	0.846	0.928	.008	18	view →
GBM	OS	Tertile	All	0.167	0.416	.017	9	view →
LGG	OS	Tertile	All	0.295	0.539	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR892C–HNSC (DFS)

Open the HNSC breakdown →